Non-alcoholic fatty liver disease (NAFLD), now renamed as Metabolic Associated Steatotic Liver Disease (MASLD), has traditionally been seen as a condition affecting adults. However, alarming data now ...
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...